Study on Aspirin and Cancer Metastasis Prevention
A new study suggests that aspirin could help prevent cancer metastasis by stimulating the immune system. Researchers found that aspirin decreases the production of a chemical that suppresses T-cells, which are crucial for attacking cancer cells. However, long-term aspirin use can pose risks such as stomach bleeding and stroke. Patients should consult their doctor before starting aspirin therapy for cancer prevention.
Key Points
- Aspirin decreases the production of a chemical that suppresses T-cells
- Study conducted on mice models, further research needed for human application
Pros
- Aspirin may reduce cancer metastasis by stimulating the immune system
- Potential for less expensive cancer treatments compared to antibody-based therapies
Cons
- Long-term aspirin use can have significant risks such as stomach bleeding and hemorrhagic stroke